Novo Nordisk ( NVO 1.34%) and Regeneron Pharmaceuticals ( REGN -0.27%), two leading drugmakers, have underperformed for most of the year, significantly lagging the broader market. These healthcare …
2 Healthcare Stocks That Are Losing to the S&P 500 This Year
view original post